Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

366 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
p53 germline polymorphisms are associated with an increased risk for breast cancer in German women.
Wang-Gohrke S, Rebbeck TR, Besenfelder W, Kreienberg R, Runnebaum IB. Wang-Gohrke S, et al. Among authors: rebbeck tr. Anticancer Res. 1998 May-Jun;18(3B):2095-9. Anticancer Res. 1998. PMID: 9677474
BRCA1 mutations in women attending clinics that evaluate the risk of breast cancer.
Couch FJ, DeShano ML, Blackwood MA, Calzone K, Stopfer J, Campeau L, Ganguly A, Rebbeck T, Weber BL. Couch FJ, et al. Among authors: rebbeck t. N Engl J Med. 1997 May 15;336(20):1409-15. doi: 10.1056/NEJM199705153362002. N Engl J Med. 1997. PMID: 9145677
Polymorphisms in PTEN in breast cancer families.
Carroll BT, Couch FJ, Rebbeck TR, Weber BL. Carroll BT, et al. Among authors: rebbeck tr. J Med Genet. 1999 Feb;36(2):94-6. J Med Genet. 1999. PMID: 10051004 Free PMC article.
Modification of BRCA1-associated breast cancer risk by the polymorphic androgen-receptor CAG repeat.
Rebbeck TR, Kantoff PW, Krithivas K, Neuhausen S, Blackwood MA, Godwin AK, Daly MB, Narod SA, Garber JE, Lynch HT, Weber BL, Brown M. Rebbeck TR, et al. Am J Hum Genet. 1999 May;64(5):1371-7. doi: 10.1086/302366. Am J Hum Genet. 1999. PMID: 10205268 Free PMC article.
Evaluation of genotype data in clinical risk assessment: methods and application to BRCA1, BRCA2, and N-acetyl transferase-2 genotypes in breast cancer.
Rebbeck TR, Rogatko A, Viana MA. Rebbeck TR, et al. Genet Test. 1997-1998;1(3):157-64. doi: 10.1089/gte.1997.1.157. Genet Test. 1997. PMID: 10464641
Breast cancer risk after bilateral prophylactic oophorectomy in BRCA1 mutation carriers.
Rebbeck TR, Levin AM, Eisen A, Snyder C, Watson P, Cannon-Albright L, Isaacs C, Olopade O, Garber JE, Godwin AK, Daly MB, Narod SA, Neuhausen SL, Lynch HT, Weber BL. Rebbeck TR, et al. J Natl Cancer Inst. 1999 Sep 1;91(17):1475-9. doi: 10.1093/jnci/91.17.1475. J Natl Cancer Inst. 1999. PMID: 10469748
Inherited genetic predisposition in breast cancer. A population-based perspective.
Rebbeck TR. Rebbeck TR. Cancer. 1999 Dec 1;86(11 Suppl):2493-501. doi: 10.1002/(sici)1097-0142(19991201)86:11+<2493::aid-cncr6>3.0.co;2-z. Cancer. 1999. PMID: 10630175 Review.
Modification of BRCA1- and BRCA2-associated breast cancer risk by AIB1 genotype and reproductive history.
Rebbeck TR, Wang Y, Kantoff PW, Krithivas K, Neuhausen SL, Godwin AK, Daly MB, Narod SA, Brunet JS, Vesprini D, Garber JE, Lynch HT, Weber BL, Brown M. Rebbeck TR, et al. Cancer Res. 2001 Jul 15;61(14):5420-4. Cancer Res. 2001. PMID: 11454686
Progesterone receptor variant increases ovarian cancer risk in BRCA1 and BRCA2 mutation carriers who were never exposed to oral contraceptives.
Runnebaum IB, Wang-Gohrke S, Vesprini D, Kreienberg R, Lynch H, Moslehi R, Ghadirian P, Weber B, Godwin AK, Risch H, Garber J, Lerman C, Olopade OI, Foulkes WD, Karlan B, Warner E, Rosen B, Rebbeck T, Tonin P, Dubé MP, Kieback DG, Narod SA. Runnebaum IB, et al. Among authors: rebbeck t. Pharmacogenetics. 2001 Oct;11(7):635-8. doi: 10.1097/00008571-200110000-00010. Pharmacogenetics. 2001. PMID: 11668223
BRCA1 and BRCA2 mutation frequency in women evaluated in a breast cancer risk evaluation clinic.
Shih HA, Couch FJ, Nathanson KL, Blackwood MA, Rebbeck TR, Armstrong KA, Calzone K, Stopfer J, Seal S, Stratton MR, Weber BL. Shih HA, et al. Among authors: rebbeck tr. J Clin Oncol. 2002 Feb 15;20(4):994-9. doi: 10.1200/JCO.2002.20.4.994. J Clin Oncol. 2002. PMID: 11844822
366 results
Jump to page
Feedback